Surmodics (SRDX) Competitors $34.75 +0.37 (+1.08%) As of 11:08 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends SRDX vs. IART, ATEC, OFIX, ANGO, ARAY, RMTI, RSLS, ABT, ISRG, and BSXShould you be buying Surmodics stock or one of its competitors? The main competitors of Surmodics include Integra LifeSciences (IART), Alphatec (ATEC), Orthofix Medical (OFIX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), and Boston Scientific (BSX). These companies are all part of the "health care equipment" industry. Surmodics vs. Integra LifeSciences Alphatec Orthofix Medical AngioDynamics Accuray Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical Boston Scientific Surmodics (NASDAQ:SRDX) and Integra LifeSciences (NASDAQ:IART) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership. Do analysts recommend SRDX or IART? Surmodics presently has a consensus price target of $50.00, indicating a potential upside of 43.88%. Integra LifeSciences has a consensus price target of $23.00, indicating a potential upside of 5.78%. Given Surmodics' stronger consensus rating and higher probable upside, equities research analysts plainly believe Surmodics is more favorable than Integra LifeSciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Surmodics 0 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Integra LifeSciences 3 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.75 Is SRDX or IART more profitable? Integra LifeSciences has a net margin of -0.42% compared to Surmodics' net margin of -11.48%. Integra LifeSciences' return on equity of 12.35% beat Surmodics' return on equity.Company Net Margins Return on Equity Return on Assets Surmodics-11.48% -4.39% -2.95% Integra LifeSciences -0.42%12.35%4.82% Which has higher earnings & valuation, SRDX or IART? Integra LifeSciences has higher revenue and earnings than Surmodics. Integra LifeSciences is trading at a lower price-to-earnings ratio than Surmodics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSurmodics$126.08M3.94-$11.54M-$1.01-34.41Integra LifeSciences$1.54B1.09$67.74M-$0.09-241.57 Does the media favor SRDX or IART? In the previous week, Integra LifeSciences had 3 more articles in the media than Surmodics. MarketBeat recorded 4 mentions for Integra LifeSciences and 1 mentions for Surmodics. Integra LifeSciences' average media sentiment score of 0.18 beat Surmodics' score of 0.00 indicating that Integra LifeSciences is being referred to more favorably in the news media. Company Overall Sentiment Surmodics Neutral Integra LifeSciences Neutral Which has more volatility & risk, SRDX or IART? Surmodics has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500. Comparatively, Integra LifeSciences has a beta of 1.17, meaning that its share price is 17% more volatile than the S&P 500. Do insiders & institutionals have more ownership in SRDX or IART? 96.6% of Surmodics shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 8.9% of Surmodics shares are held by insiders. Comparatively, 3.1% of Integra LifeSciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the MarketBeat Community believe in SRDX or IART? Integra LifeSciences received 100 more outperform votes than Surmodics when rated by MarketBeat users. However, 62.29% of users gave Surmodics an outperform vote while only 56.83% of users gave Integra LifeSciences an outperform vote. CompanyUnderperformOutperformSurmodicsOutperform Votes33762.29% Underperform Votes20437.71% Integra LifeSciencesOutperform Votes43756.83% Underperform Votes33243.17% SummaryIntegra LifeSciences beats Surmodics on 10 of the 18 factors compared between the two stocks. Get Surmodics News Delivered to You Automatically Sign up to receive the latest news and ratings for SRDX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRDX vs. The Competition Export to ExcelMetricSurmodicsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$496.93M$4.63B$5.82B$9.07BDividend YieldN/A39.91%4.78%3.85%P/E Ratio-34.4130.6726.0019.05Price / Sales3.9450.34462.5080.21Price / Cash110.9051.2344.0437.47Price / Book4.446.677.694.74Net Income-$11.54M$90.13M$3.18B$245.69M7 Day Performance1.91%-0.90%-0.93%-1.30%1 Month Performance-7.33%-0.65%1.18%-0.98%1 Year Performance10.32%16.24%17.98%15.66% Surmodics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRDXSurmodics3.5267 of 5 stars$34.75+1.1%$50.00+43.9%+8.9%$496.93M$126.08M-34.41450Analyst RevisionIARTIntegra LifeSciences2.6075 of 5 stars$24.18-0.3%$23.00-4.9%-51.3%$1.87B$1.54B-268.643,946ATECAlphatec4.3669 of 5 stars$10.74-1.3%$17.56+63.5%-30.8%$1.52B$572.74M-8.39700OFIXOrthofix Medical3.1737 of 5 stars$18.61+1.6%$23.33+25.4%+31.5%$711.09M$746.64M-5.951,634Upcoming EarningsANGOAngioDynamics4.4207 of 5 stars$10.34-1.8%$13.00+25.7%+74.8%$418.46M$303.91M-1.84760ARAYAccuray2.4436 of 5 stars$2.23-2.2%N/A-20.9%$229.31M$446.55M-44.601,040Analyst DowngradeGap DownRMTIRockwell Medical3.8181 of 5 stars$1.85-0.5%$6.00+224.3%+34.3%$59.79M$83.61M-37.00300News CoverageRSLSReShape Lifesciences0.5383 of 5 stars$2.33-8.3%N/A-87.2%$1.70M$8.68M0.0050Gap DownHigh Trading VolumeABTAbbott Laboratories4.8511 of 5 stars$130.63-0.9%$133.06+1.9%+14.2%$226.56B$41.95B17.08114,000Positive NewsISRGIntuitive Surgical4.5809 of 5 stars$595.55+0.7%$613.10+2.9%+60.6%$212.12B$8.35B92.9113,676Positive NewsBSXBoston Scientific4.6016 of 5 stars$106.20+0.1%$107.39+1.1%+59.1%$156.51B$16.75B84.9648,000Analyst DowngradeInsider TradePositive News Related Companies and Tools Related Companies Integra LifeSciences Competitors Alphatec Competitors Orthofix Medical Competitors AngioDynamics Competitors Accuray Competitors Rockwell Medical Competitors ReShape Lifesciences Competitors Abbott Laboratories Competitors Intuitive Surgical Competitors Boston Scientific Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SRDX) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surmodics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surmodics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SRDX Stock Alerts